WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2'3701 Infant (under 12 months) mortality rate: 02
GDP / capita (US$): 8'0771 Child (under 5 years) mortality rate: 02

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 775  765  755  744  732  564  536  413 
Births 13  14  14  14  14  16  20  18 
Surviving infants 13  13  13  13  14  15  18  16 
Pop. less than 5 years 66  67  69  71  72  75  90  73 
Pop. less than 15 years 208  210  212  214  216  229  233  176 
Female 15-49 years 207  203  199  195  190  132  116  91 

Number of reported cases

(Click for retrospective incidence data for Bhutan)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
  27 
Measles
ChartChart ChartChart
  11  10  418  173  1'642 
Mumps
ChartChart
  620  206  20  198  262  1'967 
Pertussis
ChartChart
  12  18  464 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bhutan)
Vaccine year result method % card seen                                                
BCG 2011  100     91  99*  99*  97  95  95  97  87  43 
DTP1 2011  100     91  99*  99*  97  97  93  99 
DTP3 2011  99     91  99  99  97  97  95  92  84 
DTP4         
IPV1          43 
HepB_BD          78  78  64  60  29 
HepB3 2011  99     91  99  99  97  97  95  98 
Hib3          99  97  97 
JapEnc         
MCV1          97  97  94  95  95  79  21 
MCV2          94  92  89  90  95 
PCV1         
PCV3         
Pol3 2011  97     91  98  98  97  97  95  98  84 
Rota1         
RotaC         
RCV1          93  97  94  95  95 
TT2plus 2007  97  EPI   98  91  93  39  79  80  76  63 
PAB         
VAD1          82  97  44 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bhutan)
BCG
ChartChart
  99  99  97  95  95  97  99  43 
DTP1
ChartChart
  99  99  97  97  98  96  98  25 
DTP3
ChartChart
  99  99  97  97  95  92  96 
HepB3
ChartChart
  99  99  97  97  95  98 
HepB_BD
ChartChart
  78  78  64  60  29 
Hib3
ChartChart
  99  99  97  97 
IPV1
ChartChart
  43 
MCV1
ChartChart
  97  97  94  95  95  78  93  21 
MCV2
ChartChart
  94  92  89  90  95 
PAB
ChartChart
  89  83  83  89  89  85  63 
PCV3
ChartChart
 
Pol3
ChartChart
  98  98  97  97  95  98  96 
RCV1
ChartChart
  97  97  94  95  95 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 24 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 12 years; +2, +6 months; Yes Grade 6 girls
HepB Birth;
IPV 14 weeks; Yes
MR 9, 24 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Td 6, 12 years; Yes and pregnant women

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2014-2018  2013-2018  2'013  2'013  2009-2013  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20  20  20  20  20 

System performance

Total Nº districts in country number   20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 20  20  20  19  19  18  17 
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  95  95  90  85 
Nº districts with measles (MCV1) coverage >=95% number 15  11  13  14 
% of districts with MCV1 coverage >=95% From 0 to 100%   55  45  40  40  65  70 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 43  31          63 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.